An immunohistochemical study of 234 samples of cervical tissues with antibodies to VEGF and podoplanin (PDPN) with varying degrees of CIN revealed that VEGF expression was significantly stronger in HSIL samples compared to LSIL, and the simultaneous assessment of VEGF and PDPN can provide additional information for possible tactics for treating patients with CIN [66]. The gene discussed is VEGFA; the disease is cervical squamous intraepithelial neoplasia.